Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study-Reference-Cited by-同舟云学术

Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study

Published:2024-06-22 Issue:7 Volume:40 Page:1171-1178
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Karadurmus Nuri¹,Kaplan Muhammet Ali²,Sendur Mehmet Ali Nahit³,Urun Yuksel⁴,Demirci Umut⁵,Karaca Saziye Burcak⁶,Goktas Aydin Sabin⁷^ORCID,Aykan Musa Baris¹,Bilici Ahmet⁷,Sezer Ahmet⁸,Yilmaz Ulku⁹,Abali Huseyin¹⁰,Yumuk Perran Fulden¹¹,Degirmencioglu Serkan¹²,Demirkazik Ahmet⁴,Paydas Semra¹³,Mirili Cem¹³,Turna Hande¹⁴,Kargi Aysegul¹⁵,Ozdogan Mustafa¹⁵,Guven Deniz Can¹⁶^ORCID,Ozguroglu Mustafa¹⁴,Kilickap Saadettin¹⁷

Affiliation:

1. Medical Oncology Department, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Türkiye

2. Medical Oncology Unit, Memorial Diyarbakir Hospital, Diyarbakir, Türkiye

3. Department of Medical Oncology, Ankara City Hospital, Ankara, Türkiye

4. Medical Oncology Division, Department of Internal Diseases, Ankara University Medical Faculty, Ankara, Türkiye

5. Medical Oncology Unit, Memorial Ankara Hospital, Ankara, Türkiye

6. Department of Internal Diseases, Ege University Medical Faculty, Izmir, Türkiye

7. Medical Oncology Unit, Bagcilar Medipol Mega University Hospital, Istanbul, Türkiye

8. Medical Oncology Unit, Adana Dr. Turgut Noyan Application and Research Center, Baskent University, Adana, Türkiye

9. Chest Diseases Unit, Ankara Ataturk Sanatory Education and Research Hospital, Ankara, Türkiye

10. Medical Oncology Unit, Acibadem Adana Hospital, Adana, Türkiye

11. Medical Oncology Unit, Marmara University Medical Faculty, Istanbul, Türkiye

12. Department of Internal Diseases, Pamukkale University Medical Faculty, Denizli, Türkiye

13. Department of Medical Oncology, Cukurova University Medical Faculty, Adana, Türkiye

14. Medical Oncology Division, Department of Internal Medicine, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Türkiye

15. Medical Oncology Unit, Medstar Antalya Hospital Cancer Center, Antalya, Türkiye

16. Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Türkiye

17. Medical Oncology Unit, Liv Hospital Ankara, Ankara, Türkiye

Funder

BMS Türkiye

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2359026

Reference28 articles.

1. World Health Organization: Cancer [Internet]. WHO. c2023 [cited 2022 Sep 13]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer

2. The 2015 World Health Organization Classification of Lung Tumors

3. Pathology of Lung Cancer

4. Lung cancer: A review

5. Prognostic factors affecting survival in cases with lung cancer [a lung cancer mapping project in Turkey (LCMPT)];Goksel T;Eur Respir J,2013